274 related articles for article (PubMed ID: 1093610)
41. A comparative trial of Mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar.
Dixon KE; Williams RG; Pongsupat T; Pitaktong U; Phintuyothin P
Trans R Soc Trop Med Hyg; 1982; 76(5):664-7. PubMed ID: 6758224
[TBL] [Abstract][Full Text] [Related]
42. Chemosuppression of malaria by the triple combination mefloquine/sulfadoxine/pyrimethamine: a field trial in an endemic area in Malaysia.
Navaratnam V; Mohamad M; Hussain S; Kumar A; Jamaludin A; Sulaiman I; Mahsufi S; Selliah K
Trans R Soc Trop Med Hyg; 1989; 83(6):755-9. PubMed ID: 2694509
[TBL] [Abstract][Full Text] [Related]
43. Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988.
Hansford CF
S Afr Med J; 1989 Nov; 76(10):546-7. PubMed ID: 2686047
[TBL] [Abstract][Full Text] [Related]
44. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
[TBL] [Abstract][Full Text] [Related]
45. Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
Pearson RD; Hewlett EL
Ann Intern Med; 1987 May; 106(5):714-8. PubMed ID: 3551713
[TBL] [Abstract][Full Text] [Related]
46. Kenyan chloroquin, fansidar and quninine resistant P. Falciparum.
Turner GD
Cent Afr J Med; 1984 Jul; 30(7):136-7. PubMed ID: 6386173
[No Abstract] [Full Text] [Related]
47. Comparison of in vitro pyrimethamine assays and in vivo response to sulphadoxine-pyrimethamine in Plasmodium falciparum from Papua New Guinea.
Lamont G; Darlow B
Trans R Soc Trop Med Hyg; 1982; 76(6):797-9. PubMed ID: 6761908
[TBL] [Abstract][Full Text] [Related]
48. Effects of Fansidar on chloroquine-resistant Plasmodium falciparum in Pakistan.
Strickland GT; Khaliq AA; Sarwar M; Hassan H; Pervez M; Fox E
Am J Trop Med Hyg; 1986 Jan; 35(1):61-5. PubMed ID: 3511752
[TBL] [Abstract][Full Text] [Related]
49. The in vivo sensitivity of Plasmodium falciparum to chloroquine and to sulphadoxine-pyrimethamine combination in Ibadan, Nigeria.
Olatunde A; Salako LA; Walker O
Trans R Soc Trop Med Hyg; 1981; 75(6):848-50. PubMed ID: 7036438
[TBL] [Abstract][Full Text] [Related]
50. [Plasmodium falciparum drug resistance and sulfadoxine-pyrimethamine in Africa].
Randriamanjaka JR; Le Bras J; Charmot G; Coulaud JP
Bull Soc Pathol Exot Filiales; 1989; 82(3):381-4. PubMed ID: 2670291
[TBL] [Abstract][Full Text] [Related]
51. Plasmodium falciparum resistant to fansidar.
Rubis C; Wilson M; Lamont G; Cooke R
Med J Aust; 1981 Jun; 1(13):718. PubMed ID: 7024758
[No Abstract] [Full Text] [Related]
52. A case of Plasmodium falciparum infection resistant to chloroquine.
Assefa T
Ethiop Med J; 1987 Oct; 25(4):209-10. PubMed ID: 3311731
[No Abstract] [Full Text] [Related]
53. Imported cases of chloroquine-resistant falciparum malaria in Iran.
Edrissian GH; Shahabi S; Pishva E; Hajseyed-Javadi J; Khaleghian B; Ghorbani M; Emadi AM; Afshar A; Saghari H
Bull Soc Pathol Exot Filiales; 1986; 79(2):217-21. PubMed ID: 3524879
[TBL] [Abstract][Full Text] [Related]
54. Fansidar resistant Plasmodium falciparum infection in Surinam.
Oostburg BF; Jozefzoon LM
Trop Geogr Med; 1983 Sep; 35(3):243-7. PubMed ID: 6359597
[TBL] [Abstract][Full Text] [Related]
55. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children of Papua New Guinea. II. Plasmodium vivax.
Darlow B; Vrbova H; Gibney S; Jolley D; Stace J; Alpers M
Am J Trop Med Hyg; 1982 Jan; 31(1):10-3. PubMed ID: 7036765
[TBL] [Abstract][Full Text] [Related]
56. The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results.
Schapira A; Bygbjerg IC; Jepsen S; Flachs H; Bentzon MW
Am J Trop Med Hyg; 1986 Mar; 35(2):239-45. PubMed ID: 3513641
[TBL] [Abstract][Full Text] [Related]
57. [Unsuccessful effect of sulfadoxine-pyrimethamine in the treatment of falciparum malaria in Tanzania].
Vestergaard Olsen V
Ugeskr Laeger; 1983 Mar; 145(10):751. PubMed ID: 6344376
[No Abstract] [Full Text] [Related]
58. [Effectiveness of treatment with chloroquine, fansidar and dabequin of Plasmodium falciparum carriers, residing in a hyperendemic focus of malaria (the city of Bagamoyo, Northeastern Tanzania)].
Kuznetsov RL; Kilama V; Peĭn D; Kampbell SS; Stori D
Med Parazitol (Mosk); 1985; (4):15-9. PubMed ID: 3903459
[No Abstract] [Full Text] [Related]
59. Response of Plasmodium falciparum infections to pyrimethamine-sulfadoxine in Thailand.
Rieckmann K; Suebsaeng L; Rooney W
Am J Trop Med Hyg; 1987 Sep; 37(2):211-6. PubMed ID: 3310675
[TBL] [Abstract][Full Text] [Related]
60. Sulfadoxine-pyrimethamine resistant malaria from west or central Africa.
Gubler J
Br Med J (Clin Res Ed); 1988 Feb; 296(6619):433. PubMed ID: 3125942
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
